HSTRF - Hollister Biosciences Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0755
+0.0025 (+3.42%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.0730
Open0.0806
BidN/A x N/A
AskN/A x N/A
Day's Range0.0720 - 0.0806
52 Week Range0.0250 - 1.1300
Volume416,257
Avg. Volume205,577
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.2740
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Hollister Biosciences Inc. CEO Provides Corporate Update

    VANCOUVER, May 13, 2020 /CNW/ - Hollister Biosciences Inc. (CSE: HOLL, OTC: HSTRF,  FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to provide a Corporate Update from CEO, Carl Saling. Said Carl Saling, CEO Hollister. In many states across the country cannabis was deemed an essential business and Hollister has been able to stay operational in all the states in which it operates.

  • Hollister Biosciences Inc. Division Hollister Cannabis Co Becomes Official Brand Partner for Chronic Relief 4/20 Fundraiser in Support of Feeding America
    CNW Group

    Hollister Biosciences Inc. Division Hollister Cannabis Co Becomes Official Brand Partner for Chronic Relief 4/20 Fundraiser in Support of Feeding America

    Hollister Biosciences Inc., the creator of California's #1 hash-infused pre-roll HashBone, joins a global group of cannabis' biggest stars for an unprecedented live web broadcast on one of the world's "highest" holidays to feed hungry families during the global coronavirus pandemic. VANCOUVER, April 20, 2020 /CNW/ - Hollister Biosciences Inc. (CSE: HOLL, OTC: HSTRF, FRANKFURT: HOB) (the "Company" or "Hollister") - through its Hollister Cannabis Co division, has become an official brand partner of Farechild Events' Chronic Relief 4/20 fundraiser. An extraordinary line-up of game-changing cannabis personalities, activists, actors, musicians, athletes, journalists and brands have banded together for Chronic Relief - a ground-breaking free telethon live-web broadcast, with 100% of all funds raised via donation given to Feeding America COVID-19 Response Fund (501c3).

  • CNW Group

    Hollister Biosciences Inc. Announces DTC Eligibility

    Hollister Biosciences Inc. Announces DTC Eligibility

  • Hollister Biosciences Closes Transformational Acquisition of Rapidly Growing Venom Extracts Adding Over $16.4 Million In 2019 Revenue and $2.5 Million in EBITDA
    CNW Group

    Hollister Biosciences Closes Transformational Acquisition of Rapidly Growing Venom Extracts Adding Over $16.4 Million In 2019 Revenue and $2.5 Million in EBITDA

    VANCOUVER, March 30, 2020 /CNW/ - Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the "Company" or "Hollister"), a diversified cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce that further to the signing of the definitive agreement, as amended (the "SEA"), the Company has now closed its transformational acquisition of Venom Extracts ("Venom Extracts"), a leading Arizona cannabis extract brand and one of the state's largest producers of award-winning medical cannabis distillate and related products (the "Transaction"). For the year ended December 31, 2019, management of Venom Extracts reports having generated over CDN$16.4 million in revenue and over CDN$2.5 million in EBITDA from its product line of cannabis concentrates and cartridges.

  • CNW Group

    Hollister Biosciences Inc. is Making & Donating Hand Sanitizer to Hollister, CA

    Hollister Biosciences Inc., the creator of California's #1 hash-infused pre-roll HashBone, is producing thousands of bottles of hand-sanitizer for its community in wake of the coronavirus. VANCOUVER , March 24, 2020 /CNW/ - Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT : HOB, OTC: HSTRF) (the "Company" or " Hollister ") - through its Hollister Cannabis Co division, is stepping up to manufacture and distribute a few thousand bottles of hand sanitizer to Hollister, CA. A statewide "shelter at home" mandate has been issued for California , putting a halt to non-essential manufacturing and delay in distribution.

  • Hollister Biosciences Enters Letter of Intent to Acquire Alphamind Brands
    CNW Group

    Hollister Biosciences Enters Letter of Intent to Acquire Alphamind Brands

    VANCOUVER, March 11, 2020 /CNW/ - Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the "Company" or "Hollister") – a diversified cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce that the Company has entered into a letter of intent (the "LOI") on March 9th, 2020 to acquire Alphamind Brands ( "Alphamind"), a company developing legal mushroom based natural health products and conducting R&D in conjunction with accredited universities to develop psilocybin based compounds for drug development.

  • Hollister Biosciences Signs Definitive Agreement to Acquire Venom Extracts With $16.4 Million in Revenue and $2.48 Million EBITDA
    CNW Group

    Hollister Biosciences Signs Definitive Agreement to Acquire Venom Extracts With $16.4 Million in Revenue and $2.48 Million EBITDA

    VANCOUVER , March 6, 2020 /CNW/ - Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT : HOB, OTC: HSTRF) (the "Company" or " Hollister ") – a diversified cannabis branding company with products in 220 dispensaries throughout California , is pleased to announce the Company has entered into a definitive agreement  (the "Agreement") on March 6 th, 2020 to acquire Venom Extracts ( "Venom"), one of Arizona's premier extract brands and one of the state's largest producers of award-winning medical cannabis distillate and related products.

  • Hollister Biosciences Signs Letter of Intent to Acquire Venom Extracts With $16.4 Million In Revenue And $2.48 Million EBITDA
    CNW Group

    Hollister Biosciences Signs Letter of Intent to Acquire Venom Extracts With $16.4 Million In Revenue And $2.48 Million EBITDA

    VANCOUVER , Feb. 25, 2020 /CNW/ - Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT : HOB, OTC: HSTRF) (the "Company" or " Hollister ") – a vertically integrated cannabis branding company with products in 220 dispensaries throughout California , is pleased to announce that the Company signed a Letter of Intent ("LOI") on February 20 th, 2020 to acquire Venom Extracts ( "Venom"), one of Arizona's premier extract brands and one of the state's largest producers of award-winning medical cannabis distillate and related products.

  • CNW Group

    Supreme Cannabis to Close Acquisition of Premium Wellness Brand and Extraction Company Blissco

    Blissco to expand Supreme Cannabis' portfolio of premium cannabis brands into the wellness category. Will provide in-house extraction capabilities for other Supreme Cannabis brands, including 7ACRES. Will expand Supreme Cannabis' product portfolio to include CBD and THC wellness products and pre-rolls.

  • GlobeNewswire

    Blissco Cannabis Corp. Announces 99.28% Shareholder Approval of Arrangement with The Supreme Cannabis Company, Inc.

    Blissco Cannabis Corp. (the Company or Blissco) (CSE:BLIS) (HSTRF) (FRA:GQ4B) is pleased to announce that, at the special meeting of shareholders of Blissco (Blissco Shareholders) held today (the Meeting), Blissco Shareholders voted in favour of a special resolution (the Arrangement Resolution) to approve the previously announced plan of arrangement (the Arrangement) between Blissco and The Supreme Cannabis Company, Inc. (Supreme Cannabis) (FIRE.TO) (SPRWF) (53S1.F). Subject to the terms and conditions of an arrangement agreement (the Arrangement Agreement) between Blissco and Supreme Cannabis dated May 16, 2019, Supreme Cannabis will acquire all of the issued and outstanding common shares of Blissco (Blissco Shares) not already owned by Supreme Cannabis.

  • GlobeNewswire

    Blissco Announces Q1 2020 Financial Results

    1st quarter reporting company revenue of $742,28521 dried flower & pre-rolled Blissco products for sale in select Canadian provincesSubsequent to quarter end, entered into.

  • GlobeNewswire

    Blissco Announces Q4 2019 Financial Results

    VANCOUVER, British Columbia, May 31, 2019 -- Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA:GQ4B), (“Blissco” or the “Company”) is a Canadian wellness cannabis brand.